mtPCDI: a machine learning-based prognostic model for prostate cancer recurrence

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Prostate cancer recurrence poses a significant clinical challenge.
• Understanding the interplay between cellular processes like mitochondrial function and programmed cell death (PCD) is crucial for predicting outcomes.

Purpose of the Study:

• To develop a prognostic model for forecasting prostate cancer recurrence.
• To investigate the relationship between mitochondrial function, PCD, and cancer recurrence.

Main Methods:

• Analysis of four gene expression datasets from TCGA and GEO.
• Univariate Cox regression to identify prognostic genes.
• Application of machine learning algorithms to build a predictive model.

Main Results:

• Identification of key genes associated with mitochondrial function and PCD.
• Development of a mitochondrial-related programmed cell death index (mtPCDI).
• Lower mtPCDI correlated with increased immune activity and better recurrence prognosis.

Conclusions:

• The mtPCDI serves as an effective predictor of prostate cancer patient prognosis.
• mtPCDI facilitates personalized risk assessment and therapeutic decision-making.
• The study provides insights into biological mechanisms underlying prostate cancer recurrence.